These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
457 related articles for article (PubMed ID: 23998063)
1. The concomitant consumption of cod liver oil causes a reduction in the daily diclofenac sodium usage in rheumatoid arthritis patients: a pilot study. Gupta VK; Khan ZY; Ahmad M J Clin Diagn Res; 2013 Jul; 7(7):1347-51. PubMed ID: 23998063 [TBL] [Abstract][Full Text] [Related]
2. Valdecoxib is as effective as diclofenac in the management of rheumatoid arthritis with a lower incidence of gastroduodenal ulcers: results of a 26-week trial. Pavelka K; Recker DP; Verburg KM Rheumatology (Oxford); 2003 Oct; 42(10):1207-15. PubMed ID: 12810937 [TBL] [Abstract][Full Text] [Related]
3. Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal antiinflammatory drugs. Clinical and immune correlates. Kremer JM; Lawrence DA; Petrillo GF; Litts LL; Mullaly PM; Rynes RI; Stocker RP; Parhami N; Greenstein NS; Fuchs BR Arthritis Rheum; 1995 Aug; 38(8):1107-14. PubMed ID: 7639807 [TBL] [Abstract][Full Text] [Related]
4. Cod liver oil (n-3 fatty acids) as an non-steroidal anti-inflammatory drug sparing agent in rheumatoid arthritis. Galarraga B; Ho M; Youssef HM; Hill A; McMahon H; Hall C; Ogston S; Nuki G; Belch JJ Rheumatology (Oxford); 2008 May; 47(5):665-9. PubMed ID: 18362100 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the analgesic efficacy of rofecoxib and enteric-coated diclofenac sodium in the treatment of postoperative dental pain: a randomized, placebo-controlled clinical trial. Chang DJ; Desjardins PJ; Chen E; Polis AB; McAvoy M; Mockoviak SH; Geba GP Clin Ther; 2002 Apr; 24(4):490-503. PubMed ID: 12017395 [TBL] [Abstract][Full Text] [Related]
6. A single-blind, randomized, controlled trial to assess the efficacy and tolerability of rofecoxib, diclofenac sodium, and meloxicam in patients with acute gouty arthritis. Cheng TT; Lai HM; Chiu CK; Chem YC Clin Ther; 2004 Mar; 26(3):399-406. PubMed ID: 15110132 [TBL] [Abstract][Full Text] [Related]
7. Analgesic effectiveness of celecoxib and diclofenac in patients with osteoarthritis of the hip requiring joint replacement surgery: a 12-week, multicenter, randomized, double-blind, parallel-group, double-dummy, noninferiority study. Emery P; Koncz T; Pan S; Lowry S Clin Ther; 2008 Jan; 30(1):70-83. PubMed ID: 18343244 [TBL] [Abstract][Full Text] [Related]
8. Analgesic safety and efficacy of diclofenac sodium softgels on postoperative third molar extraction pain. Zuniga JR; Phillips CL; Shugars D; Lyon JA; Peroutka SJ; Swarbrick J; Bon C J Oral Maxillofac Surg; 2004 Jul; 62(7):806-15. PubMed ID: 15218558 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the Effects of Daily Single-Dose Use of Flurbiprofen, Diclofenac Sodium, and Tenoxicam on Postoperative Pain, Swelling, and Trismus: A Randomized Double-Blind Study. Kaplan V; Eroğlu CN J Oral Maxillofac Surg; 2016 Oct; 74(10):1946.e1-6. PubMed ID: 27311846 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of low-dose submicron diclofenac for the treatment of osteoarthritis pain: a 12 week, phase 3 study. Gibofsky A; Hochberg MC; Jaros MJ; Young CL Curr Med Res Opin; 2014 Sep; 30(9):1883-93. PubMed ID: 25050589 [TBL] [Abstract][Full Text] [Related]
11. The efficacy of topical sesame oil in patients with knee osteoarthritis: A randomized double-blinded active-controlled non-inferiority clinical trial. Askari A; Ravansalar SA; Naghizadeh MM; Mosavat SH; Khodadoost M; Jazani AM; Hashempur MH Complement Ther Med; 2019 Dec; 47():102183. PubMed ID: 31780006 [TBL] [Abstract][Full Text] [Related]
12. Diclofenac sodium (Voltaren) and ibuprofen in rheumatoid arthritis. A randomized double-blind study. Meinicke J; Danneskiold-Samsøe B Scand J Rheumatol Suppl; 1980; 35():1-8. PubMed ID: 7006069 [TBL] [Abstract][Full Text] [Related]
13. Dose response and safety study of meloxicam up to 22.5 mg daily in rheumatoid arthritis: a 12 week multicenter, double blind, dose response study versus placebo and diclofenac. Furst DE; Kolba KS; Fleischmann R; Silverfield J; Greenwald M; Roth S; Hall DB; Roszko PJ; J Rheumatol; 2002 Mar; 29(3):436-46. PubMed ID: 11908554 [TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1998 Aug; 473():1-326. PubMed ID: 12571677 [TBL] [Abstract][Full Text] [Related]
15. Preliminary study of highly cross-linked hyaluronic acid-based combination therapy for management of knee osteoarthritis-related pain. Palmieri B; Rottigni V; Iannitti T Drug Des Devel Ther; 2013; 7():7-12. PubMed ID: 23326188 [TBL] [Abstract][Full Text] [Related]
16. Relative benefit-risk comparing diclofenac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis: a network meta-analysis. van Walsem A; Pandhi S; Nixon RM; Guyot P; Karabis A; Moore RA Arthritis Res Ther; 2015 Mar; 17(1):66. PubMed ID: 25879879 [TBL] [Abstract][Full Text] [Related]
17. Treating rheumatoid arthritis early with disease modifying drugs reduces joint damage: a randomised double blind trial of sulphasalazine vs diclofenac sodium. Choy EH; Scott DL; Kingsley GH; Williams P; Wojtulewski J; Papasavvas G; Henderson E; Macfarlane D; Erhardt C; Young A; Plant MJ; Panayi GS Clin Exp Rheumatol; 2002; 20(3):351-8. PubMed ID: 12102471 [TBL] [Abstract][Full Text] [Related]
18. Lumiracoxib in the treatment of osteoarthritis, rheumatoid arthritis and acute postoperative dental pain: results of three dose-response studies. Schnitzer TJ; Gitton X; Jayawardene S; Sloan VS Curr Med Res Opin; 2005 Jan; 21(1):151-61. PubMed ID: 15881487 [TBL] [Abstract][Full Text] [Related]
19. [Comparison of the efficacy and safety of nabumetone and diclofenac sodium in the treatment of patients with rheumatoid arthritis]. Zhonghua Yi Xue Za Zhi; 2001 May; 81(9):557-60. PubMed ID: 11809123 [TBL] [Abstract][Full Text] [Related]
20. A randomized, open-label, comparative, 6-month trial of oral ultra-low doses of antibodies to tumor necrosis factor-alpha and diclofenac in rheumatoid arthritis. Dugina JL; Petrov VI; Babayeva AR; Martyushev-Poklad AV; Tcherevkova EV; Epstein OI; Sergeeva SA Int J Tissue React; 2005; 27(1):15-21. PubMed ID: 15847101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]